Comparison of induced neurons reveals slower structural and functional maturation in humans than in apes.


Journal

eLife
ISSN: 2050-084X
Titre abrégé: Elife
Pays: England
ID NLM: 101579614

Informations de publication

Date de publication:
20 01 2021
Historique:
received: 26 05 2020
accepted: 19 01 2021
pubmed: 21 1 2021
medline: 1 2 2022
entrez: 20 1 2021
Statut: epublish

Résumé

We generated induced excitatory neurons (iNeurons, iNs) from chimpanzee, bonobo, and human stem cells by expressing the transcription factor neurogenin-2 (NGN2). Single-cell RNA sequencing showed that genes involved in dendrite and synapse development are expressed earlier during iNs maturation in the chimpanzee and bonobo than the human cells. In accordance, during the first 2 weeks of differentiation, chimpanzee and bonobo iNs showed repetitive action potentials and more spontaneous excitatory activity than human iNs, and extended neurites of higher total length. However, the axons of human iNs were slightly longer at 5 weeks of differentiation. The timing of the establishment of neuronal polarity did not differ between the species. Chimpanzee, bonobo, and human neurites eventually reached the same level of structural complexity. Thus, human iNs develop slower than chimpanzee and bonobo iNs, and this difference in timing likely depends on functions downstream of NGN2.

Identifiants

pubmed: 33470930
doi: 10.7554/eLife.59323
pii: 59323
pmc: PMC7870144
doi:
pii:

Types de publication

Comparative Study Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

© 2021, Schörnig et al.

Déclaration de conflit d'intérêts

MS, XJ, LF, SE, AW, SK, TS, NN, BT, BP, WH, ET No competing interests declared

Références

Curr Opin Neurobiol. 2010 Aug;20(4):450-6
pubmed: 20430610
Cell Rep. 2019 May 14;27(7):2212-2228.e7
pubmed: 31091457
J Neurosci. 2001 Sep 1;21(17):RC163
pubmed: 11511694
Dev Biol. 2012 Apr 15;364(2):114-27
pubmed: 22326227
Elife. 2016 Oct 06;5:
pubmed: 27710767
Cell. 2012 May 11;149(4):923-35
pubmed: 22559944
Cell. 1987 Jun 19;49(6):785-91
pubmed: 3581170
Neuron. 2004 Sep 30;44(1):59-73
pubmed: 15450160
Elife. 2019 Feb 07;8:
pubmed: 30730291
Proc Natl Acad Sci U S A. 2016 Mar 22;113(12):3371-6
pubmed: 26951672
Front Neuroanat. 2011 Feb 10;5:2
pubmed: 21347276
Nat Rev Neurosci. 2009 Oct;10(10):724-35
pubmed: 19763105
Cell Stem Cell. 2016 Apr 7;18(4):467-80
pubmed: 27049876
Nature. 2019 Oct;574(7778):418-422
pubmed: 31619793
Proc Natl Acad Sci U S A. 2011 Aug 9;108(32):13281-6
pubmed: 21788513
Nature. 2014 Dec 4;516(7529):121-5
pubmed: 25471886
Dev Neurobiol. 2012 Jul;72(7):955-71
pubmed: 22684946
Elife. 2016 Sep 26;5:
pubmed: 27669147
Physiol Rev. 2005 Jul;85(3):883-941
pubmed: 15987798
Neuron. 2013 Jun 5;78(5):785-98
pubmed: 23764284
J Neurosci. 2015 May 20;35(20):7674-81
pubmed: 25995458
Neuron. 2019 Jul 17;103(2):217-234.e4
pubmed: 31171447
Prog Brain Res. 2012;195:325-40
pubmed: 22230634
Neuron. 2013 Oct 30;80(3):633-47
pubmed: 24183016
Nat Rev Neurosci. 2004 Dec;5(12):931-42
pubmed: 15550948
Annu Rev Neurosci. 2014;37:17-38
pubmed: 25032491
Proc Natl Acad Sci U S A. 2011 Dec 13;108(50):20018-23
pubmed: 22128334
Development. 2014 Jun;141(11):2182-94
pubmed: 24866113
Proc Natl Acad Sci U S A. 2009 Apr 7;106(14):5743-8
pubmed: 19307592
Neuron. 2017 Feb 22;93(4):806-821.e9
pubmed: 28162808
Development. 2017 Sep 15;144(18):3336-3348
pubmed: 28807903
Front Syst Neurosci. 2015 Dec 18;9:173
pubmed: 26733825
J Comp Neurol. 2013 Dec 15;521(18):4249-59
pubmed: 23839595
Nature. 2016 Jun 08;534(7607):391-5
pubmed: 27281220
Ann N Y Acad Sci. 1999 Apr 30;868:13-26
pubmed: 10414278
Cell Rep. 2017 Dec 26;21(13):3970-3986
pubmed: 29281841
Neuron. 2019 Dec 4;104(5):972-986.e6
pubmed: 31761708
Curr Biol. 2017 Mar 6;27(5):714-720
pubmed: 28162899
Eur J Neurosci. 2000 Mar;12(3):793-802
pubmed: 10762308
Am J Phys Anthropol. 2001 Mar;114(3):224-41
pubmed: 11241188
Cell. 2011 Jul 8;146(1):18-36
pubmed: 21729779
Front Neuroanat. 2011 May 16;5:29
pubmed: 21647212
Nat Biotechnol. 2018 Jan;36(1):89-94
pubmed: 29227470
Cell. 2019 Jun 13;177(7):1888-1902.e21
pubmed: 31178118
Proc Natl Acad Sci U S A. 2010 Jul 20;107(29):13129-34
pubmed: 20615956
J Vis Exp. 2017 Jan 8;(119):
pubmed: 28117798
Science. 2017 Oct 27;358(6362):478-482
pubmed: 29074767
Cell. 2012 May 11;149(4):912-22
pubmed: 22559943
Proc Natl Acad Sci U S A. 2013 Jun 18;110 Suppl 2:10395-401
pubmed: 23754422
Nat Neurosci. 2008 Nov;11(11):1283-93
pubmed: 18849985
Neurochem Res. 2007 Feb;32(2):363-76
pubmed: 17191130
Trends Neurosci. 2004 Feb;27(2):98-103
pubmed: 15102489
Cell Rep. 2018 May 22;23(8):2509-2523
pubmed: 29791859
Source Code Biol Med. 2017 Apr 13;12:6
pubmed: 28413437
Cereb Cortex. 2002 Jan;12(1):37-53
pubmed: 11734531
Cereb Cortex. 2013 Oct;23(10):2429-36
pubmed: 22875862
Cell Res. 2016 Jan;26(1):83-102
pubmed: 26691752

Auteurs

Maria Schörnig (M)

Max Planck Institute for Evolutionary Anthropology, Leipzig, Germany.

Xiangchun Ju (X)

Max Planck Institute for Evolutionary Anthropology, Leipzig, Germany.

Luise Fast (L)

Max Planck Institute for Evolutionary Anthropology, Leipzig, Germany.

Sebastian Ebert (S)

Max Planck Institute for Evolutionary Anthropology, Leipzig, Germany.

Anne Weigert (A)

Max Planck Institute for Evolutionary Anthropology, Leipzig, Germany.

Sabina Kanton (S)

Max Planck Institute for Evolutionary Anthropology, Leipzig, Germany.

Theresa Schaffer (T)

Max Planck Institute for Evolutionary Anthropology, Leipzig, Germany.

Nael Nadif Kasri (N)

Department of Human Genetics and Department of Cognitive Neuroscience, Donders Institute for Brain, Cognition, and Behavior, Radboudumc, Nijmegen, Netherlands.

Barbara Treutlein (B)

Max Planck Institute for Evolutionary Anthropology, Leipzig, Germany.

Benjamin Marco Peter (BM)

Max Planck Institute for Evolutionary Anthropology, Leipzig, Germany.

Wulf Hevers (W)

Max Planck Institute for Evolutionary Anthropology, Leipzig, Germany.

Elena Taverna (E)

Max Planck Institute for Evolutionary Anthropology, Leipzig, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH